Molecular and genetic mechanisms in brain arteriovenous malformations: new insights and future perspectives

被引:0
作者
Sandra Vetiska
Thomas Wälchli
Ivan Radovanovic
Moncef Berhouma
机构
[1] University Health Network,Krembil Brain Institute
[2] Toronto Western Hospital,Division of Neurosurgery, Department of Surgery
[3] University Health Network,Group of CNS Angiogenesis and Neurovascular Link
[4] University of Toronto,Division of Neurosurgery
[5] Neuroscience Center Zurich,Department of Neurosurgery
[6] and Division of Neurosurgery,CREATIS Lab, CNRS UMR 5220
[7] University and University Hospital Zurich,undefined
[8] and Swiss Federal Institute of Technology (ETH) Zurich,undefined
[9] University Hospital Zurich,undefined
[10] University Hospital of Dijon Bourgogne,undefined
[11] INSERM U1294,undefined
[12] Lyon 1,undefined
[13] University,undefined
来源
Neurosurgical Review | 2022年 / 45卷
关键词
Angiogenesis; Brain arteriovenous malformations; Genetics; Pathogenesis, Vasculogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Brain arteriovenous malformations (bAVMs) are rare vascular lesions made of shunts between cerebral arteries and veins without the interposition of a capillary bed. The majority of bAVMs are asymptomatic, but some may be revealed by seizures and potentially life-threatening brain hemorrhage. The management of unruptured bAVMs remains a matter of debate. Significant progress in the understanding of their pathogenesis has been made during the last decade, particularly using genome sequencing and biomolecular analysis. Herein, we comprehensively review the recent molecular and genetic advances in the study of bAVMs that not only allow a better understanding of the genesis and growth of bAVMs, but also open new insights in medical treatment perspectives.
引用
收藏
页码:3573 / 3593
页数:20
相关论文
共 1839 条
[1]  
Achrol AS(2005)Tumor Necrosis factor- -238G>a promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations Stroke 37 231-234
[2]  
Pawlikowska L(2003)Molecular control of arterial-venous blood vessel identity J Anat 202 105-112
[3]  
McCulloch CE(2008)Brothers and sisters: molecular insights into arterial-venous heterogeneity Circ Res 103 929-939
[4]  
Poon KYT(2018)Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy J Clin Invest 128 1496-1508
[5]  
Ha C(2002)Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis J Neurol Neurosurg Psychiatry 73 547-551
[6]  
Zaroff JG(2014)Outcome after conservative management or intervention for unruptured brain arteriovenous malformations JAMA 311 1661-1669
[7]  
Johnston SC(2010)MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function Arterioscler Thromb Vasc Biol 30 1118-1126
[8]  
Lee C(2017)Germline Loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling Circulation 136 1037-1048
[9]  
Lawton MT(2014)Therapeutic modulation of Notch signalling — are we there yet? Nat Publ Group 13 357-378
[10]  
Sidney S(2011)Notch signaling: simplicity in design, versatility in function Development 138 3593-3612